Clinical trial
First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial…
NCT00392054 · Population Health Research Institute, Other · Completed
Key facts
| NCT number | NCT00392054 |
|---|---|
| Title | First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment (The RAAFT Study) |
| Official title | First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment: A Multi-center Randomized Trial |
| Acronym | RAAFT |
| Lead sponsor | Population Health Research Institute, Other |
| Collaborators | Johnson & Johnson Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Drug, Procedure |
| Interventions | Pulmonary Vein Isolation performed by Catheter Ablation, Conventional Antiarrhythmic Drug Therapy |
| Enrollment | 127 |
| Start date | Aug 1, 2006 |
| Primary completion | Feb 1, 2012 |
| Completion | Feb 1, 2012 |
| First posted | Oct 25, 2006 |
| Last update posted | Jan 31, 2020 |
| Countries | Canada, Czechia, Germany, Italy, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: